betulinic acid has been researched along with Astrocytoma, Grade IV in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Cai, J; Chen, AT; Chen, Q; Deng, G; Gao, L; Li, Y; Liu, B; Sun, Q; Tan, Y; Tian, D; Tong, S; Wang, Y; Xu, Y; Ye, Z; Zhang, S; Zhao, L; Zhou, J | 1 |
Bache, M; Bernhardt, S; Hein, A; Kappler, M; Paschke, R; Passin, S; Taubert, H; Vordermark, D; Wichmann, H; Zschornak, M | 1 |
Debatin, KM; Enzenmüller, S; Fulda, S; Gonzalez, P; Karpel-Massler, G | 1 |
Benner, A; Debatin, KM; Herold-Mende, C; Jeremias, I; Steiner, HH | 1 |
Debatin, KM; Fulda, S; Jeremias, I; Pietsch, T; Steiner, HH | 1 |
El-Deiry, WS; Meng, RD | 1 |
6 other study(ies) available for betulinic acid and Astrocytoma, Grade IV
Article | Year |
---|---|
Betulinic acid self-assembled nanoparticles for effective treatment of glioblastoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Betulinic Acid; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Glioblastoma; Humans; Mice; Nanoparticles; Pentacyclic Triterpenes; Receptors, Cannabinoid; Xenograft Model Antitumor Assays | 2022 |
Betulinic acid derivatives NVX-207 and B10 for treatment of glioblastoma--an in vitro study of cytotoxicity and radiosensitization.
Topics: Antineoplastic Agents, Phytogenic; Betulinic Acid; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Glioblastoma; Glucosides; Humans; Inhibitor of Apoptosis Proteins; Pentacyclic Triterpenes; Poly(ADP-ribose) Polymerases; Propanolamines; Radiation, Ionizing; Survivin; Triterpenes | 2014 |
GDC-0941 enhances the lysosomal compartment via TFEB and primes glioblastoma cells to lysosomal membrane permeabilization and cell death.
Topics: Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; bcl-2-Associated X Protein; Betulinic Acid; Caspase 3; Cell Death; Cell Line, Tumor; Central Nervous System Neoplasms; Glioblastoma; Humans; Indazoles; Intracellular Membranes; Lysosomes; Matrix Metalloproteinases; Pentacyclic Triterpenes; Permeability; Sulfonamides; Triterpenes | 2013 |
Cell death induction by betulinic acid, ceramide and TRAIL in primary glioblastoma multiforme cells.
Topics: Adult; Aged; Antineoplastic Agents; Apoptosis Regulatory Proteins; Betulinic Acid; Brain Neoplasms; Cell Culture Techniques; Cell Death; Ceramides; Female; Glioblastoma; Humans; Male; Membrane Glycoproteins; Middle Aged; Pentacyclic Triterpenes; Retrospective Studies; TNF-Related Apoptosis-Inducing Ligand; Triterpenes; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2004 |
Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Betulinic Acid; Brain Neoplasms; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Medulloblastoma; Pentacyclic Triterpenes; Triterpenes; Tumor Cells, Cultured | 1999 |
p53-independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-gamma.
Topics: Antibiotics, Antineoplastic; Apoptosis; Betulinic Acid; Colonic Neoplasms; Dactinomycin; Dexamethasone; DNA-Binding Proteins; Female; Glioblastoma; Glucocorticoids; Humans; Interferon-gamma; Melanoma; Mutation; Naphthoquinones; Ovarian Neoplasms; Pentacyclic Triterpenes; Prednisolone; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; RNA, Messenger; STAT1 Transcription Factor; Trans-Activators; Triterpenes; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Up-Regulation | 2001 |